News
InflaRx (NASDAQ:IFRX) is one of the best penny stocks under $1 to buy now. As May came to an end, InflaRx announced that its ...
A systematic review of 63 cases finds that pyoderma gangrenosum in pregnancy is frequently misdiagnosed.
9d
24/7 Wall St. on MSN4 High-Yield Blue-Chip Pharmaceutical Giants Offer Huge Total Return Potential
Here are four high-yield blue-chip pharmaceutical stocks positioned to outperform and offer huge total return potential.
The data, from the Centers for Disease Control and Prevention, also showed a significant increase in COVID-related emergency room visits for young children.
Many Southeast, Southern and West Coast states are likely seeing an increase in COVID cases.
The Nimbus variant, or NB.1.8.1, is a strain of SARS-CoV-2, which causes COVID-19. Alongside the usual symptoms of COVID-19, it can cause a razor blade sensation in the throat and gastrointestinal ...
As the U.S. approaches the midpoint of summer, the CDC is reporting cases of the virus are growing or likely growing in dozens of states.
The Food and Drug Administration (FDA) granted full approval on Thursday to Moderna’s COVID-19 vaccine for children, making it the first COVID shot for kids aged 6 months to 11 years old that is ...
Moderna’s Covid vaccine for children has been given full FDA approval, making it the first such shot for kids in the U.S. that will no longer be administered under an emergency use authorization.
The new XFG SARS-CoV-2 variant is behind a COVID-19 surge in Southeast Asia and has been designated by the World Health Organization as a “variant under monitoring.” ...
While you are soaking up the summer sun, doctors say you can still get sick, including from two new COVID strains that are going around.
A new COVID-19 variant named "Nimbus" has been detected in the U.S. and is spreading rapidly. Here's what to know about symptoms and vaccines.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results